Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant

BACKGROUND: Patients with treatment-resistant depression (TRD) report significant deficits in physical and mental health, as well as severely impaired health-related quality of life (HRQoL) and functioning. Esketamine effectively enhances the daily functioning in these patients while also improving...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamieson, Carol, Popova, Vanina, Daly, Ella, Cooper, Kimberly, Drevets, Wayne C., Rozjabek, Heather M., Singh, Jaskaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169482/
https://www.ncbi.nlm.nih.gov/pubmed/37158911
http://dx.doi.org/10.1186/s12955-023-02113-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169482/
https://www.ncbi.nlm.nih.gov/pubmed/37158911
http://dx.doi.org/10.1186/s12955-023-02113-1

Ejemplares similares